PDS Biotechnology (PDSB) Capital Leases (2022 - 2026)
PDS Biotechnology's (PDSB) quarterly Capital Leases came in at $25686.0 in Q4 2025, down 58.47% YoY from $61853.0 in Q4 2024, and down 23.36% on a QoQ basis from $33517.0 in Q3 2025.
PDS Biotechnology (PDSB) Capital Leases (2022 - 2026) Analysis & Trends
PDS Biotechnology (PDSB) has 4 years of Capital Leases data on file, last reported at $25686.0 in Q4 2025.
- Quarterly Capital Leases fell 58.47% year-over-year to $25686.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $25686.0 (down 58.47% YoY) and the FY2025 annual result came in at $25686.0, down 58.47% from the prior year.
- Capital Leases declined to $25686.0 in Q4 2025, from $33517.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $165292.0 in Q1 2023 to a low of $25686.0 in Q4 2025.
- A 4-year average of $93441.1 and a median of $85384.0 in 2024 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2023 — Capital Leases soared 78.14% — and 2025, when it sank 58.47%.
- Tracing PDSB's Capital Leases over 4 years: stood at $164013.0 in 2022, then decreased by 25.02% to $122973.0 in 2023, then sank by 49.7% to $61853.0 in 2024, then slumped by 58.47% to $25686.0 in 2025.
- The last three Capital Leases figures came in at $25686.0 (Q4 2025), $33517.0 (Q3 2025), and $41173.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | PDS Biotechnology | 11.58 Mn | 11.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9,476.00 |
| Dec 31, 2025 | 25,686.00 |
| Sep 30, 2025 | 33,517.00 |
| Jun 30, 2025 | 41,173.00 |
| Mar 31, 2025 | 48,655.00 |
| Dec 31, 2024 | 61,853.00 |
| Sep 30, 2024 | 77,659.00 |
| Jun 30, 2024 | 93,109.00 |
| Mar 31, 2024 | 108,211.00 |
| Dec 31, 2023 | 122,973.00 |
| Sep 30, 2023 | 137,401.00 |
| Jun 30, 2023 | 151,505.00 |
| Mar 31, 2023 | 165,292.00 |
| Dec 31, 2022 | 164,013.00 |
| Sep 30, 2022 | 77,129.00 |